ICD-10-GM

ICD-10-GM-Code Y50.2

You are here: Startseite > ICD-10-GM > V01-Y98 > Y40-Y84 > Y40-Y59 > Y50

- ICD-10-GM
Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme (ICD-10)
- V01-Y98
Äußere Ursachen von Morbidität und Mortalität
- Y40-Y84
Komplikationen bei der medizinischen und chirurgischen Behandlung
- Y40-Y59
Unerwünschte Nebenwirkungen bei therapeutischer Anwendung von Arzneimitteln, Drogen oder biologisch aktiven Substanzen
- Y50
Stimulanzien des Zentralnervensystems, anderenorts nicht klassifiziert

Y50.2

Methylxanthine, anderenorts nicht klassifiziert

ICD-10-GM Code Y50.2 für Methylxanthine, anderenorts nicht klassifiziert

Koffein

Exkl.: Aminophyllin (Y55.6)

Theobromin (Y55.6)

Theophyllin (Y55.6)

ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us